Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
Clinical trial NCT00860262 · COMPLETED
Trial details
- NCT number
- NCT00860262
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2009-12-01
- Enrollment
- 858
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.